INTRODUCTION 1
Although accidental trauma with inoculation of the fungus, Sporotrichum schenckii, probably accounts for most cases of cutaneous-lymphatic sporotrichosis, systemic disease may be primarily the result of inadequate Dr. Moore's present address is: Forest Hill Veterans Administration Hospital, Augusta, Ga. 30904. Dr. Gentry's present address is: Baylor College of Medicine, Texas Medical Center, Houston, Tex. 77025.
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host immune defense. The overwhelming male predominance cannot be explained by outdoor exposure alone and the rarity in children, but predisposition among immunosuppressed hosts and alcoholics also suggests that endogenous host factors may be of major import (1, 2) .
The immune mechanisms involved in preventing or combating systemic sporotrichosis are incompletely understood but apparently include both humoral and cellular responses since patients with defects in antibody production or cellular immunity may be predisposed. The relative importance of the cellular immune response has not been well defined, but the severe and often fatal infections of patients with cancer and those on immunosuppressive therapy, both conditions known to depress cellular immune competence, suggest that cellular immunity may provide primary host defense. Moreover, fungal infections such as systemic candidiasis have been reported in children with thymic deficiency syndromes (3, 4) .
The present study was undertaken to develop an in vitro assay of cellular immunity to S. schenckii and to compare this assay to in vivo skin testing. The in vitro method employed was lymphocyte blastogenesis in response to the sporothrix antigen. The application of these assays for diagnosis of a patient with articular sporotrichosis is also presented. In addition, similar assays of cellular immunity to Candida albicans and Coccidioides immitis were evaluated in adult males and females to delineate any cross-reactivity between these agents which might then account for the apparent protection of females from infection with S. schenckii.
METHODS
Lymphocyte blastogenesis. Lymphocyte reactivity to the three fungal agents was evaluated by determining lymphocyte blastogenesis during incubation with the fungal antigens (5 (6) . The cell suspension was washed twice in culture medium and the lymphocytes were adjusted to a concentration of 2 X 106/ml in RPMI 1640 medium with Hepes buffer, containing 100 U of penicillin per ml and 100 sug of streptomycin per ml and 20%o autologous serum. In some experiments, fetal calf serum and AB-positive serum were also employed. Using a biopipet. 0.1 ml of the lymphocyte suspension (2 X 10' lymphocytes) was mixed with an equal volume of fungal antigen material in one well of sterile flat-bottom microtest plates. All cultures were prepared in triplicate and three dilutions of each fungal antigen were included along with control cultures containing lymphocytes incubated with medium alone. The plates were covered with sterile plastic lids and cultures were incubated for 5 days. 24 h before harvest, 0.05 ml of RPMI 1640 medium containing 0.1 uCi of [2- "4C] thymidine was added to each well. A harvesting apparatus previously described (7) was employed for the separation of reacting cells on glass-fiber filters, for washing of these cells, and for recovery of the radioactive material incorporated by stimulated lymphocytes. The glass-fiber disks were then dried in an oven and transferred to vials containing 5 ml of scintillation fluid for counting in a Beckman Liquid Scintillation Spectrometer (Beckman Instruments, Inc., Fullerton, Calif. Fungal antigens. S. schenckii antigen used in the in vitro assay of lymphocyte blastogenesis was prepared from the mycelial phase of the fungus which had been originally isolated from a patient with systemic sporotrichosis. The organisms was grown on Sabouraud's glucose agar at 30'C. The organism was harvested, washed three times with tissue culture medium and homogenized in a Dounce homogenizer. Large particles were allowed to settle, after which the supernate was collected and serial dilutions subsequently tested for antigenic reactivity as described above. Approximately 200 mg per ml of antigenic material constituted the stock preparation. This material was later heat inactivated at 560C for 60 min after it was demonstrated that this process did not alter the sensitivity or specificity of the assay. A dilution of 1: 200 was the optimal concentration for most positive responders. Mexico, and perhaps among nursery workers in many countries (1, 2) . Moreover, the incidence of systemic infection appears to be increasing, especially in the immunologically compromised host (1). In previous reviews of systemic sporotrichosis (1, 2) one-half of reported cases were observed in patients with underlying malignant disease.
Present methods of diagnosis include primarily fungal culture and serological methods. For cutaneous-lymphatic sporotrichosis, fungal cultures offer the most direct and reliable laboratory procedure, but cultures are often negative in systemic disease since adequate specimens are difficult to obtain. For this reason, the clinician must usually rely on other methods of diagnosis. Serological assays, including slide latex agglutination, tube agglutination, complement fixation, immunodiffusion, and indirect fluorescent antibody techniques are available in a few research laboratories and, depending on the assay employed, are capable of detecting between 56 and 94% of the cases of sporotrichosis (8, 9) . Reports indicate that these methods are specific and reliable. However, there is increasing evidence that development of cellular immunity precedes antibody production (10) Of great interest is the cross-reactivity between C. albicans and S. schenckii as demonstrated in the assays of lymphocyte blastogenesis. This is most probably on the basis of antigens common to the two mycotic agents which contribute to development of the cellular immune response. Such cross-reactivity has also been observed in previous serological studies when the whole yeast agglutination assay was employed (13, 14) . Other serological methods have not demonstrated similar crossreactivity (8, 9) suggesting that either the assays of lymphocyte blastogenesis and yeast agglutination are more sensitive or that different antigens are responsible for stimulating some antibody responses.
Most reported cases of sporotrichosis have occurred in males and the observed cross-reactivity between C. albicans and S. schenckii may in part account for the lower incidence of infection in females. A recent report (1) indicated that only 1 of 26 patients with systemic sporotrichosis was a female. Even in children there has been a male predominance (15) for sporothrix infection further implying protection in the female host early in life.
The present laboratory data demonstrate that virtually all normal females have positive in vitro responses (i.e. a BI > 3) to C. albicans and that their responses are significantly higher than those of normal male donors. A higher percentage of females than males also have positive in vitro responses to S. schenckii but this appears most related to an increased sensitivity to C. albicans (Fig. 1) .
It is well recognized that C. albicans is a frequent inhabitant of the female vaginal tract, thus providing persistent antigenic stimulation during much of life. Males certainly do not carry this mycotic agent as commonly and it is not surprising, therefore, to observe less consistent and lower cellular immune responses to C. albicans. Other groups we have evaluated who have exhibited decreased skin sensitivity and lymphocyte blastogenesis to C. albicans have included patients with malignancy and those on immunosuppressive therapy; these patients are also ones observed to have a greater predisposition to sporothrix infection (1, 2).
In conclusion, the present data indirectly support the hypothesis that intact cellular immune mechanisms in combination with exposure to the fungus C. albicans protect the host from systemic infection with S. schenckii; however such cross resistance remains to be proven. Many aspects of sporothrix infection have yet to be adequately defined, particularly the role of environmental exposure to S. schenckii and the relative importance of antibody production. There is still no direct evidence that cell-mediated immunity protects against sporotrichosis. Sporotrichosis is, of course, too uncommon for any one medical center to accumulate meaningful data, so such information can best be provided by combining the experience of many centers.
Because present therapy for systemic sporotrichosis must include the highly toxic antifungal antibiotic agent, amphotericin B, a better understanding of host defense mechanisms may direct advances in improving management. If cellular immunity is of major importance, as is suggested by our present understanding of fungal dis- 
